Abu Dhabi achieved a medical milestone on January 5, 2026, with the UAE’s first gene-therapy injection for inherited blood disorders. CASGEVY, utilizing CRISPR-Cas9, corrects faulty DNA in conditions like sickle cell disease and beta thalassemia, shifting from symptom management to actual genetic correction.
